HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marguerite Koutsoukos Selected Research

W-135 and Y tetanus toxoid conjugate vaccine C tetravalent meningococcal serogroups A

1/2020Safety, reactogenicity, and immunogenicity of a chimpanzee adenovirus vectored Ebola vaccine in children in Africa: a randomised, observer-blind, placebo-controlled, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marguerite Koutsoukos Research Topics

Disease

10Infections
01/2023 - 08/2005
7COVID-19
11/2023 - 01/2022
4HIV Infections (HIV Infection)
01/2022 - 04/2011
2Virus Diseases (Viral Diseases)
03/2021 - 01/2021
2Vaccinia
01/2020 - 01/2020
2Measles
12/2013 - 12/2012
2Tuberculosis (Tuberculoses)
11/2010 - 07/2009
1Injection Site Reaction
11/2023
1Fever (Fevers)
01/2020
1Pain (Aches)
01/2020
1Angioedema
02/2016
1Viremia
12/2012
1HIV Seropositivity
04/2011
1Hypersensitivity (Allergy)
03/2008
1Malaria
03/2007
1Acquired Immunodeficiency Syndrome (AIDS)
01/2007

Drug/Important Bio-Agent (IBA)

26VaccinesIBA
11/2023 - 08/2005
7Proteins (Proteins, Gene)FDA Link
10/2023 - 04/2011
2Combined VaccinesIBA
11/2023 - 01/2023
2Neutralizing AntibodiesIBA
01/2022 - 08/2005
2AIDS VaccinesIBA
01/2021 - 04/2011
2AIDSVAXIBA
01/2021 - 01/2018
2AntigensIBA
05/2016 - 03/2008
1Nucleic AcidsIBA
11/2023
1N-(2-cyanoethylene)urea (BA 1)IBA
01/2023
1N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2023
1env Gene ProductsIBA
01/2022
1A-factor (Streptomyces)IBA
01/2022
1A-Form DNA (A-DNA)IBA
01/2022
1AIDSVAX B-EIBA
01/2021
1Immunoglobulin G (IgG)IBA
11/2020
1W-135 and Y tetanus toxoid conjugate vaccine C tetravalent meningococcal serogroups AIBA
01/2020
1MF59 oil emulsionIBA
01/2018
1Broadly Neutralizing AntibodiesIBA
11/2017
1Therapeutic UsesIBA
05/2014
1Viral RNAIBA
12/2012
1Protein Subunits (Protein Subunit)IBA
01/2012
1PolyproteinsIBA
04/2011
1AntibodiesIBA
04/2011
1RTS malaria vaccineIBA
03/2007
1Recombinant ProteinsIBA
01/2007
1Indicators and Reagents (Reagents)IBA
08/2005

Therapy/Procedure

1Contraindications
10/2023
1Drug Therapy (Chemotherapy)
01/2022
1Intramuscular Injections
01/2018
1Highly Active Antiretroviral Therapy (HAART)
01/2012